SecBot SecBot
SC TO-C ·Filed Oct 27, 2026

QGEN

QIAGEN N.V.
BULLISH
Impact 7/10
Horizonweeks Processed4d 13h ago SEC0001104659-26-119256
Tender offer communication
Actionable Insight ▲ Bullish

Monitor for BaFin approval and formal commencement of the tender offer. The offer price of EUR 46.50 per share represents a significant premium; shareholders should review the offer document and recommendation statement when published.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled: T+1d
QGEN ▲ +0.02% at T+1d
LONG call ✓ call won +0.02% · α vs SPY +0.40% · entry $50.33 → $50.34
Next anchor: T+5d in 2d
Entry = T+0 close
Oct 27, 2026
via day close
T+1d
+0.02%
call +0.02% · α +0.40%
$50.34
settled 4d ago
T+5d
Pending
in 2d
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

EQT Private Equity, through Crown NL Bidco B.V., announced a planned tender offer to acquire all outstanding ordinary shares of QIAGEN N.V. for EUR 46.50 per share in cash, pursuant to a Business Combination Agreement dated October 21, 2026. The tender offer has not yet commenced and is subject to regulatory approvals, including from BaFin, and other conditions. This SC TO-C filing is a preliminary communication before the offer formally launches.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Offer price: EUR 46.50 per share in cash
  • Acquisition by Crown NL Bidco B.V., a wholly owned subsidiary of Crown NL Midco B.V., backed by EQT XI Investments and CPP Investment Board Europe Inc.
  • Business Combination Agreement signed on October 21, 2026
  • Tender offer has not yet commenced; subject to BaFin approval and other conditions
  • Target board supportive as indicated by signed agreement

Financial Impact

EUR 46.50 per share cash offer for all outstanding shares of QIAGEN

share priceenterprise value

Risk Factors

  • Regulatory approvals (BaFin and others) may not be obtained or may be subject to conditions
  • Possibility of competing offers
  • Conditions to the tender offer may not be satisfied or waived
  • Uncertainty regarding the number of shares tendered

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC TO-C Filing (Primary)0001104659-26-119256
Document: tm2628053d2_ex99-1.htm0001104659-26-119256
Document: 0001104659-26-119256-index-headers.html0001104659-26-119256
Document: 0001104659-26-119256-index.html0001104659-26-119256
Document: 0001104659-26-119256.txt0001104659-26-119256
3 reports for QGEN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for QGEN, sortable and filterable
TypeNow
Oct 27, 2026
4d ago
SC TO-C
BULLISH ★ 7/10
$50.33 $50.34▲ +0.02%▲ +0.40%$50.22 (−0.22%)
Oct 23, 2026
9d ago
6-K
BULLISH ★ 8/10
$50.39 $50.37▼ −0.04%▼ −0.75%$50.22 (−0.34%)
Oct 22, 2026
9d ago
SC TO-C
BULLISH ★ 8/10
$50.22 $50.39▲ +0.34%▲ +0.86%$50.22 (+0.00%)
Showing 3 of 3

US Market Status

Market Closed · Opens Mon (27h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026